osteosarcoma
Showing 1 - 25 of 517
Osteosarcoma Trial (Tucidinostat, Apatinib)
Not yet recruiting
- Osteosarcoma
- Tucidinostat, Apatinib
- (no location specified)
Nov 5, 2023
An Organoid-based Functional Precision Medicine Trial in
Not yet recruiting
- Osteosarcoma
- standard of care biopsy
- (no location specified)
Sep 26, 2023
Local Relapse After High Grade Osteosarcoma
Recruiting
- Osteosarcoma
-
Bologna, BO, Italy
- +1 more
Aug 24, 2023
Osteosarcoma Trial (Surufatinib plus chemo, Chemotherapy)
Not yet recruiting
- Osteosarcoma
- Surufatinib plus chemotherapy
- Chemotherapy
- (no location specified)
Jun 29, 2023
Osteosarcoma, Soft Tissue Sarcoma Trial in Shanghai (NK510)
Recruiting
- Osteosarcoma
- Soft Tissue Sarcoma
-
Shanghai, ChinaShanghai General Hospital
Oct 31, 2023
Soluble B7-H3 as a Biomarker for Osteosarcoma
Recruiting
- Biomarker
- +3 more
- ELISA: enzyme-linked immunosorbent assay
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jul 5, 2023
Osteosarcoma Trial in Shanghai (metastasectomy and pre-operative immunotherapy (gemcitabine and penpulimab ) and stereotactic
Recruiting
- Osteosarcoma
- metastasectomy and pre-operative immunotherapy (gemcitabine and penpulimab ) and stereotactic body radiotherapy
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University, School of Medici
Nov 1, 2023
3D Printed Personalized Extendable Prosthesis
Completed
- Osteosarcoma in Children
- 3D printed personalized extendable prosthesis
-
Chongqing, Chongqing, ChinaChildren's Hospital of Chongqing Medical University
Mar 30, 2023
Osteosarcoma, Osteosarcoma in Children, Osteosarcoma Recurrent Trial in United States (Regorafenib 40 MG, Regorafenib 20MG,
Recruiting
- Osteosarcoma
- +3 more
- Regorafenib 40 MG
- +2 more
-
Los Angeles, California
- +7 more
Jan 19, 2023
Pulmonary Osteosarcoma Trial (RNA-LP vaccine)
Not yet recruiting
- Pulmonary Osteosarcoma
- RNA-LP vaccine
- (no location specified)
Jan 25, 2023
Osteosarcoma, Bone Tumor, Bone Sarcoma Trial
Not yet recruiting
- Osteosarcoma
- +25 more
- (no location specified)
Aug 24, 2022
Construction of Microfluidic Exosome Chip for Diagnosis of Lung
Completed
- Osteosarcoma
- Pulmonary Metastases
-
Shanghai, Shanghai, ChinaRuijin Hospital Shanghai Jiao Tong University School of Medicine
Nov 14, 2022
Patients With Osteosarcoma
Not yet recruiting
- Osteosarcoma
- (no location specified)
Sep 6, 2022
Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Recurrent Ewing Sarcoma Trial in France (Cabozantinib S-malate, Laboratory
Active, not recruiting
- Metastatic Ewing Sarcoma
- +9 more
- Cabozantinib S-malate
- Laboratory Biomarker Analysis
-
Bordeaux, France
- +10 more
Nov 26, 2022
Osteosarcoma in Children Trial (Dinutuximab beta)
Not yet recruiting
- Osteosarcoma in Children
- Dinutuximab beta
- (no location specified)
Sep 23, 2022
Osteosarcoma Metastatic, Ewing's Sarcoma Metastatic Trial in Miami (Chemotherapy (gemcitabine & docetaxel) plus BIO-11006)
Active, not recruiting
- Osteosarcoma Metastatic
- Ewing's Sarcoma Metastatic
- Chemotherapy (gemcitabine & docetaxel) plus BIO-11006
-
Miami, FloridaNicklaus Children's Hospital
Nov 8, 2022
Advanced Renal Cell Carcinoma, Advanced Mesothelioma, Advanced Osteosarcoma Trial in Houston (CAR.70/IL15-transduced CB-derived
Not yet recruiting
- Advanced Renal Cell Carcinoma
- +2 more
- CAR.70/IL15-transduced CB-derived NK cells
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2023
Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)
Not yet recruiting
- Localized Osteosarcoma
- +3 more
- Cabozantinib S-malate
- +7 more
- (no location specified)
Jan 4, 2023
Osteosarcoma Trial in New York (L-MTP-PE)
Available
- Osteosarcoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
May 19, 2022
DNA Biomarkers in Tissue Samples From Patients With Osteosarcoma
Completed
- Localized Osteosarcoma
- +2 more
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Mar 11, 2022
Osteosarcoma Trial in United States (Avelumab, Questionnaires)
Active, not recruiting
- Osteosarcoma
- Avelumab
- Questionnaires
-
Los Angeles, California
- +3 more
Aug 22, 2022